Evidence map›Paper›PMID 34282206›Full record

Observational studyScientific reports2021

Frequency and phenotype of headache in covid-19: a study of 2194 patients.

David García-Azorín, Álvaro Sierra, Javier Trigo, Ana Alberdi, María Blanco, Ismael Calcerrada, Ana Cornejo, Miguel Cubero, Ana Gil, Cristina García-Iglesias and 12 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05704335 (INFLUENCEF STUDY), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05704335 unknown statusnot on this mapstarted 2022, after this paper: background citation

INFLUENCEF STUDY: Epidemiology, Risk Factors and Clinical Phenotype of Headache Associated With Influenza Infection

TypeobservationalSponsorHospital Clínico Universitario de ValladolidRan2022 to 2024Enrolled100ConditionsHeadache Disorders, Influenza -Like Illness, Head Pain, MigraineArmsQuestionnaire administration
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Impact of Long COVID on the Quality of Life.Medicina (Kaunas, Lithuania) · 2024
    Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache.International journal of environmental research and public health · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

David García-AzorínHeadache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Avenida Ramón y Cajal N° 3, 47003, Valladolid, Spain. davilink@hotmail.com.ORCID 0000-0002-3132-1064
Álvaro SierraHeadache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Avenida Ramón y Cajal N° 3, 47003, Valladolid, Spain.
Javier TrigoHeadache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Avenida Ramón y Cajal N° 3, 47003, Valladolid, Spain.
Ana AlberdiValladolid East Primary Care Basic Health Area, Valladolid, Spain.
María BlancoValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Ismael CalcerradaValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Ana CornejoValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Miguel CuberoValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Ana GilValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Cristina García-IglesiasValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Ana Guiomar LozanoValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Cristina Martínez BadilloValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Carol MontillaValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Marta MoraValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Gabriela NúñezValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Marina PaniaguaValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Carolina PérezValladolid East Primary Care Basic Health Area, Valladolid, Spain.
María RojasValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Marta RuizValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Leticia SierraValladolid East Primary Care Basic Health Area, Valladolid, Spain.
María Luisa HurtadoValladolid East Primary Care Basic Health Area, Valladolid, Spain.
Ángel Luis Guerrero PeralHeadache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Avenida Ramón y Cajal N° 3, 47003, Valladolid, Spain.
Universidad de Valladolid · ESHospital Clínico Universitario de Valladolid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To estimate the frequency of headache in patients with confirmed COVID-19 and characterize the phenotype of headache attributed to COVID-19, comparing patients depending on the need of hospitalization and sex, an observational study was done. We systematically screened all eligible patients from a reference population of 261,431 between March 8 (first case) and April 11, 2020. A physician administered a survey assessing demographic and clinical data and the phenotype of the headache. During the study period, 2194 patients out of the population at risk were diagnosed with COVID-19. Headache was described by 514/2194 patients (23.4%, 95% CI 21.7-25.3%), including 383/1614 (23.7%) outpatients and 131/580 (22.6%) inpatients. The headache phenotype was studied in detail in 458 patients (mean age, 51 years; 72% female; prior history of headache, 49%). Headache was the most frequent first symptom of COVID-19. Median headache onset was within 24 h, median duration was 7 days and persisted after 1 month in 13% of patients. Pain was bilateral (80%), predominantly frontal (71%), with pressing quality (75%), of severe intensity. Systemic symptoms were present in 98% of patients. Headache frequency and phenotype was similar in patients with and without need for hospitalization and when comparing male and female patients, being more intense in females.Trial registration: This study was supported by the Institute of Health Carlos III (ISCIII), code 07.04.467804.74011 and Regional Health Administration, Gerencia Regional de Salud, Castilla y Leon (GRS: 2289/A/2020).

Indexed as

AdolescentAdultAgedAged, 80 and overCOVID-19FemaleHeadacheHumansMaleMiddle AgedPainPhenotypeYoung Adult

Identifiers

PMID34282206
PMCPMC8290038
OpenAlexW3185937528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.